| __timestamp | Bristol-Myers Squibb Company | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 1288519000 |
| Thursday, January 1, 2015 | 16560000000 | 1465761000 |
| Friday, January 1, 2016 | 19427000000 | 1598800000 |
| Sunday, January 1, 2017 | 20776000000 | 1725300000 |
| Monday, January 1, 2018 | 22561000000 | 1627800000 |
| Tuesday, January 1, 2019 | 26145000000 | 1448800000 |
| Wednesday, January 1, 2020 | 42518000000 | 1483300000 |
| Friday, January 1, 2021 | 46385000000 | 1685500000 |
| Saturday, January 1, 2022 | 46159000000 | 1936300000 |
| Sunday, January 1, 2023 | 45006000000 | 2327500000 |
| Monday, January 1, 2024 | 48300000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success and market influence. Over the past decade, Bristol-Myers Squibb Company has demonstrated a remarkable revenue trajectory, growing by approximately 183% from 2014 to 2023. This growth is highlighted by a significant leap in 2020, where revenues surged by nearly 63% compared to the previous year. In contrast, United Therapeutics Corporation, while smaller in scale, has shown steady growth, with a 81% increase in revenue over the same period. The year 2023 marks a peak for United Therapeutics, with revenues reaching their highest point in the decade. This comparison not only underscores the competitive landscape of the pharmaceutical sector but also highlights the diverse strategies employed by these companies to achieve financial success.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
GSK plc and United Therapeutics Corporation: A Comprehensive Revenue Analysis
argenx SE or United Therapeutics Corporation: Who Leads in Yearly Revenue?
United Therapeutics Corporation and ImmunityBio, Inc.: A Comprehensive Revenue Analysis